Alexandria Co. For Pharmaceuticals & Chemical Industries

CASE:AXPH Stock Report

Market Cap: ج.م1.5b

Alexandria For Pharmaceuticals & Chemical Industries Valuation

Is AXPH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AXPH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AXPH (EGP291.56) is trading above our estimate of fair value (EGP148.9)

Significantly Below Fair Value: AXPH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AXPH?

Key metric: As AXPH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AXPH. This is calculated by dividing AXPH's market cap by their current earnings.
What is AXPH's PE Ratio?
PE Ratio6.7x
Earningsج.م216.68m
Market Capج.م1.46b

Price to Earnings Ratio vs Peers

How does AXPH's PE Ratio compare to its peers?

The above table shows the PE ratio for AXPH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average12.1x
OCPH October PharmaE
7xn/aج.م1.3b
CPCI Kahira Pharmaceuticals & Chemical Industries
6.1xn/aج.م1.5b
BIOC GlaxoSmithKlineE
28.3xn/aج.م3.4b
ADCI Arab Drug
7xn/aج.م619.3m
AXPH Alexandria For Pharmaceuticals & Chemical Industries
6.7xn/aج.م1.5b

Price-To-Earnings vs Peers: AXPH is good value based on its Price-To-Earnings Ratio (6.7x) compared to the peer average (12x).

Price to Earnings Ratio vs Industry

How does AXPH's PE Ratio compare vs other companies in the African Pharmaceuticals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
AXPH 6.7xIndustry Avg. 11.5xNo. of Companies6PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AXPH is good value based on its Price-To-Earnings Ratio (6.7x) compared to the African Pharmaceuticals industry average (10.2x).

Price to Earnings Ratio vs Fair Ratio

What is AXPH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AXPH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AXPH's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies